跳转至内容
Merck
CN
  • Robust Control of a Brain-Persisting Parasite through MHC I Presentation by Infected Neurons.

Robust Control of a Brain-Persisting Parasite through MHC I Presentation by Infected Neurons.

Cell reports (2019-06-13)
Anna Salvioni, Marcy Belloy, Aurore Lebourg, Emilie Bassot, Vincent Cantaloube-Ferrieu, Virginie Vasseur, Sophie Blanié, Roland S Liblau, Elsa Suberbielle, Ellen A Robey, Nicolas Blanchard
摘要

Control of CNS pathogens by CD8 T cells is key to avoid fatal neuroinflammation. Yet, the modalities of MHC I presentation in the brain are poorly understood. Here, we analyze the antigen presentation mechanisms underlying CD8 T cell-mediated control of the Toxoplasma gondii parasite in the CNS. We show that MHC I presentation of an efficiently processed model antigen (GRA6-OVA), even when not expressed in the bradyzoite stage, reduces cyst burden and dampens encephalitis in C57BL/6 mice. Antigen presentation assays with infected primary neurons reveal a correlation between lower MHC I presentation of tachyzoite antigens by neurons and poor parasite control in vivo. Using conditional MHC I-deficient mice, we find that neuronal MHC I presentation is required for robust restriction of T. gondii in the CNS during chronic phase, showing the importance of MHC I presentation by CNS neurons in the control of a prevalent brain pathogen.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
胞嘧啶β-D-呋喃阿拉伯糖苷 盐酸盐, crystalline
Sigma-Aldrich
抗微管相关蛋白2(MAP2)抗体, Chemicon®, from rabbit
Sigma-Aldrich
抗-MAP2 (2a+2b)抗体,小鼠单克隆 小鼠抗, clone AP-20, ascites fluid
Sigma-Aldrich
抗胶质纤维酸性蛋白(GFAP)抗体, serum, Chemicon®
Sigma-Aldrich
抗 鸡卵白蛋白 兔抗, whole antiserum
Roche
胰蛋白酶抑制剂, from chicken egg white